Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort
Open Access
- 1 September 1999
- Vol. 45 (3), 435-441
- https://doi.org/10.1136/gut.45.3.435
Abstract
BACKGROUND: Several retrospective and prospective studies report an increased prevalence of non-organ-specific autoantibodies (NOSAs) in patients with hepatitis C virus (HCV) related chronic liver disease (CLD). Some of the data so far available are controversial and the true prevalence of NOSAs in the general population is still not known.AIM: To explore the prevalence of NOSAs, their relation to different HCV genotypes, and the presence and severity of CLD in the general population of Northern Italy.PATIENTS: All 226 anti-HCV positive and 87 hepatitis B surface antigen (HBsAg) positive patients of the Dionysos cohort study were analysed and compared with sex and age matched cases (226) negative for both anti-HCV antibody and HBsAg selected from the same cohort.METHODS: Sera tested for the presence of NOSAs (anti-nuclear antibody (ANA), anti-smooth muscle antibody (SMA), and anti-liver/kidney microsomes type 1 antibody (LKM1)) were screened by indirect immunofluorescence at a 1:40 serum dilution. HCV RNA and HCV genotypes were also determined by nested polymerase chain reaction (PCR) of the 5′ non-coding region and by PCR amplification of the core region with type specific primers.RESULTS: The overall prevalence of NOSA reactivity was significantly higher in anti-HCV positive subjects than in both normal and pathological controls (25%v 6% and 7% respectively, p<0.05). ANA, SMA, and LKM1 occurred in 16, 10, and 1.3% of cases respectively. No specific association between NOSAs and a specific HCV genotype was found. NOSAs were found more often associated with more than one genotype (35.7%) and with untypable genotypes (34.6%), although the association was not statistically significant. NOSAs were associated with HCV RNA and CLD but not with the presence of cirrhosis and/or hepatocellular carcinoma. On univariate analysis, NOSA reactivity was independently associated with abnormal alanine aminotransferase (p<0.01) and γ-glutamyltranspeptidase levels (p<0.05). The risk for the presence of NOSAs was 5.1 times higher in anti-HCV subjects than in controls.CONCLUSIONS: In the general population the prevalence of NOSAs is higher in anti-HCV positive subjects than in normal or disease controls. Moreover NOSAs are associated with CLD and with a more active disease in terms of alanine aminotransferase activity.Keywords
This publication has 35 references indexed in Scilit:
- Immunologic features and HLA associations in chronic viral hepatitisGastroenterology, 1995
- Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis CJournal of Hepatology, 1994
- Non-organ specific autoantibodies associated with chronic C virus hepatitisJournal of Hepatology, 1993
- Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United StatesJournal of Hepatology, 1993
- Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitisDigestive Diseases and Sciences, 1993
- Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection.Gut, 1992
- Autoimmune chronic hepatitis type 2 manifested during interferon therapy in childrenJournal of Hepatology, 1991
- Immunomorphological characterisation of antinuclear antibodies in chronic liver disease.Journal of Clinical Pathology, 1985
- Classification of smooth muscle autoantibodies detected by immunofluorescence.Journal of Clinical Pathology, 1976
- Smooth Muscle Autoantibodies in Infectious MononucleosisBMJ, 1973